Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy
Cardiogenetics · 2020
DOI: 10.3390/cardiogenetics11010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiogenetics, 2020. Verfasst von Maria Xu und 12 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We describe a 55 year old male diagnosed with cardiomyopathy due to Fabry disease. Biochemical testing of blood spot and plasma showed low-normal alpha-galactosidase A (α-Gal A) levels. Genetic testing revealed somatic mosaicism for GLA c.901C>T, p.(Arg301Ter). Usually, males with Fabry disease due to loss of function variants in GLA show symptoms of the multisystemic features of the condition early in life, and have very low levels of the α-Gal A enzyme. This demonstrates that the diagnosis of Fabry disease in males with cardiomyopathy should still be considered even in the context of a normal plasma enzyme assay.
Zitieren
APA
Xu, M., Orsborne, C., Eden, J., Wallace, A., Church, H. J., Tylee, K., Deepak, S., Cassidy, C., Woolfson, P., Miller, C., Schmitt, M., Jovanovic, A., & Newman, W. G. (2020). Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy. Cardiogenetics. https://doi.org/10.3390/cardiogenetics11010001
Vancouver
Xu M, Orsborne C, Eden J, Wallace A, Church HJ, Tylee K, et al. Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy. Cardiogenetics. 2020. doi:10.3390/cardiogenetics11010001
BibTeX
@article{Xu2020,
author = {Xu, Maria and Orsborne, Christopher and Eden, James and Wallace, Andrew and Church, Heather J. and Tylee, Karen and Deepak, Sasalu and Cassidy, Christopher and Woolfson, Peter and Miller, Christopher and Schmitt, Matthias and Jovanovic, Ana and Newman, William G.},
title = {Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy},
journal = {Cardiogenetics},
year = {2020},
doi = {10.3390/cardiogenetics11010001}
}
EUVIMED